ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.94
-0.05%
US Tech 100
21,119.60
0.00%
S&P 500
6,068.50
0.03%
US Dollar vs CAD
1.42982
0.08%
Bitcoin
96,319.91
0.60%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MEI Pharma Inc (MEIP)

  7. MEI Pharma Inc (MEIP) News

MEIP

MEI Pharma (MEIP)

MEI Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MEIP
DateTimeSourceHeadlineSymbolCompany
01/31/20253:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
12/20/20244:20PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MEIPMEI Pharma Inc
12/20/20244:15PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MEIPMEI Pharma Inc
12/20/20244:10PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MEIPMEI Pharma Inc
11/25/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/14/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
11/12/20243:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
11/12/20243:05PMBusiness WireMEI Pharma Reports First Quarter Fiscal Year 2025 Cash PositionNASDAQ:MEIPMEI Pharma Inc
10/25/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
09/19/20244:20PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MEIPMEI Pharma Inc
09/19/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
09/19/20243:01PMBusiness WireMEI Pharma Reports Fiscal Year End 2024 Cash PositionNASDAQ:MEIPMEI Pharma Inc
08/12/20247:30AMBusiness WireMEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic AlternativesNASDAQ:MEIPMEI Pharma Inc
08/02/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
07/30/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
07/22/20244:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
07/22/20243:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MEIPMEI Pharma Inc
07/22/20247:30AMBusiness WireMEI Pharma to Consider Strategic AlternativesNASDAQ:MEIPMEI Pharma Inc
05/21/20243:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
05/21/202412:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
05/20/20243:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MEIPMEI Pharma Inc
05/09/20243:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
05/09/20243:02PMBusiness WireMEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational HighlightsNASDAQ:MEIPMEI Pharma Inc
05/09/20243:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MEIPMEI Pharma Inc
04/11/20247:02AMBusiness WireMEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344NASDAQ:MEIPMEI Pharma Inc
04/11/20247:00AMBusiness WireMEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer PatientsNASDAQ:MEIPMEI Pharma Inc
04/10/20247:00AMBusiness WireMEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology ForumNASDAQ:MEIPMEI Pharma Inc
03/26/20247:00AMBusiness WireMEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid LeukemiaNASDAQ:MEIPMEI Pharma Inc
02/28/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MEIPMEI Pharma Inc
02/21/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEIPMEI Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:MEIP

Your Recent History

USOTC
GCAN
Greater Cannabis (PK)
NASDAQ
SMCI
Super Micro Computer
USOTC
MONI
Moon Equity (PK)
USOTC
RDAR
Raadr (PK)
USOTC
ADIA
Adia Nutrition (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
GRLF
Green Leaf Innovations (PK)
USOTC
HIRU
Hiru (PK)
NYSE
IONQ
IonQ
NASDAQ
LWLG
Lightwave Logic
USOTC
ASII
Accredited Solutions (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
MGON
Megola (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads